DENTSPLY SIRONA Inc. $XRAY Shares Purchased by AQR Capital Management LLC

Key Points

• AQR Capital Management LLC increased its stake in DENTSPLY SIRONA Inc. by 119.4% in the first quarter, owning approximately 3.18% of the company, valued at $93.4 million.
• DENTSPLY SIRONA reported a quarterly earnings per share (EPS) of $0.52, exceeding analysts' expectations, and announced a quarterly dividend of $0.16 to be paid on October 10th.
• Despite recent performance, analysts have decreased price targets for DENTSPLY SIRONA, with Wells Fargo lowering their target from $16.00 to $15.00 and UBS reducing it from $25.00 to $24.00, indicating mixed sentiment on the stock.

AQR Capital Management LLC increased its stake in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY - Free Report) by 119.4% in the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 6,346,685 shares of the medical instruments supplier's stock after purchasing an additional 3,453,662 shares during the quarter. AQR Capital Management LLC owned approximately 3.18% of DENTSPLY SIRONA worth $93,423,000 as of its most recent SEC filing.

A number of other hedge funds have also recently made changes to their positions in XRAY. Invenomic Capital Management LP raised its stake in DENTSPLY SIRONA by 201.0% in the fourth quarter. Invenomic Capital Management LP now owns 2,639,161 shares of the medical instruments supplier's stock valued at $50,091,000 after buying an additional 1,762,428 shares during the last quarter. Lazard Asset Management LLC raised its stake in DENTSPLY SIRONA by 23.0% in the fourth quarter. Lazard Asset Management LLC now owns 8,044,228 shares of the medical instruments supplier's stock valued at $152,678,000 after buying an additional 1,505,928 shares during the last quarter. Price T Rowe Associates Inc. MD raised its stake in DENTSPLY SIRONA by 11.3% in the first quarter. Price T Rowe Associates Inc. MD now owns 13,961,759 shares of the medical instruments supplier's stock valued at $208,590,000 after buying an additional 1,412,517 shares during the last quarter. Voloridge Investment Management LLC purchased a new stake in DENTSPLY SIRONA in the fourth quarter valued at about $24,571,000. Finally, D. E. Shaw & Co. Inc. raised its stake in DENTSPLY SIRONA by 936.9% in the fourth quarter. D. E. Shaw & Co. Inc. now owns 997,415 shares of the medical instruments supplier's stock valued at $18,931,000 after buying an additional 901,224 shares during the last quarter. 95.70% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

XRAY has been the subject of a number of research analyst reports. Wells Fargo & Company decreased their price target on DENTSPLY SIRONA from $16.00 to $15.00 and set an "equal weight" rating for the company in a research note on Friday, August 8th. Wall Street Zen cut DENTSPLY SIRONA from a "buy" rating to a "hold" rating in a research note on Saturday, August 9th. Barrington Research decreased their price target on DENTSPLY SIRONA from $21.00 to $18.00 and set an "outperform" rating for the company in a research note on Friday, August 8th. UBS Group decreased their price target on DENTSPLY SIRONA from $25.00 to $24.00 and set a "buy" rating for the company in a research note on Friday, August 8th. Finally, Stifel Nicolaus decreased their price target on DENTSPLY SIRONA from $19.00 to $17.00 and set a "hold" rating for the company in a research note on Friday, August 8th. Two equities research analysts have rated the stock with a Buy rating and eleven have given a Hold rating to the company's stock. According to data from MarketBeat, the stock presently has an average rating of "Hold" and a consensus target price of $18.64.

DENTSPLY SIRONA Stock Performance

DENTSPLY SIRONA stock traded down $0.17 during midday trading on Wednesday, hitting $13.74. 967,395 shares of the company were exchanged, compared to its average volume of 2,973,544. The firm has a market capitalization of $2.74 billion, a PE ratio of -2.90, a price-to-earnings-growth ratio of 0.89 and a beta of 0.96. DENTSPLY SIRONA Inc. has a fifty-two week low of $12.16 and a fifty-two week high of $27.48. The business has a fifty day simple moving average of $14.90 and a two-hundred day simple moving average of $15.13. The company has a debt-to-equity ratio of 1.13, a quick ratio of 1.11 and a current ratio of 1.69.

DENTSPLY SIRONA (NASDAQ:XRAY - Get Free Report) last posted its earnings results on Thursday, August 7th. The medical instruments supplier reported $0.52 EPS for the quarter, topping the consensus estimate of $0.50 by $0.02. The firm had revenue of $936.00 million for the quarter, compared to analyst estimates of $929.67 million. DENTSPLY SIRONA had a positive return on equity of 16.33% and a negative net margin of 25.85%.DENTSPLY SIRONA's revenue for the quarter was down 4.9% compared to the same quarter last year. During the same period last year, the company earned $0.49 earnings per share. DENTSPLY SIRONA has set its FY 2025 guidance at 1.800-2.000 EPS. On average, sell-side analysts forecast that DENTSPLY SIRONA Inc. will post 1.84 earnings per share for the current year.

DENTSPLY SIRONA Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, October 10th. Investors of record on Friday, September 26th will be issued a dividend of $0.16 per share. This represents a $0.64 annualized dividend and a yield of 4.7%. The ex-dividend date of this dividend is Friday, September 26th. DENTSPLY SIRONA's dividend payout ratio (DPR) is -13.50%.

DENTSPLY SIRONA Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.